Curative Observation of Tangmaikang Particles in Combination with Intensive Insulin Therapy in Treatment of Type Diabetes Mellitus and Its Effects on Blood Lipids and ET-1
|更新时间:2024-01-04
|
Curative Observation of Tangmaikang Particles in Combination with Intensive Insulin Therapy in Treatment of Type Diabetes Mellitus and Its Effects on Blood Lipids and ET-1
Chinese Journal of Experimental Traditional Medical FormulaeVol. 22, Issue 2, Pages: 152-155(2016)
LI Huai-shan, ZHANG Ying-li, ZHAO Ning-ning, et al. Curative Observation of Tangmaikang Particles in Combination with Intensive Insulin Therapy in Treatment of Type Diabetes Mellitus and Its Effects on Blood Lipids and ET-1[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(2): 152-155.
DOI:
LI Huai-shan, ZHANG Ying-li, ZHAO Ning-ning, et al. Curative Observation of Tangmaikang Particles in Combination with Intensive Insulin Therapy in Treatment of Type Diabetes Mellitus and Its Effects on Blood Lipids and ET-1[J]. Chinese journal of experimental traditional medical formulae, 2016, 22(2): 152-155. DOI: 10.13422/j.cnki.syfjx.2016020152.
Curative Observation of Tangmaikang Particles in Combination with Intensive Insulin Therapy in Treatment of Type Diabetes Mellitus and Its Effects on Blood Lipids and ET-1
Objective:To investigate the clinical effect of Tangmaikang particles in combination with intensive insulin therapy in the treatment of type 2 diabetes mellitus (T2DM) and its effects on blood lipids and endothelin-1(ET-1). Method:The 124 cases of T2DM meeting the inclusion criteria in people's hospital of Binzhou were randomly divided into control group and observation group equally. Besides conventional treatments
the control group was also treated with intensive insulin therapy
while the observation group was also treated with Tangmaikang particles combined with intensive insulin therapy. Then
the curative efficacy
glucose-related indicators
level of blood lipids
ET-1 and incidence of hypoglycemia were compared between two groups. Result:After treatment
the effective rate in the observation group was 83.9%
significantly higher than 67.7% in the control group (P<0.05). In comparison with the control group after the treatment
glucose-related indicators in observation group were as follows:fasting plasma glucose (FPG) (7.2±0.4)VS(7.9±0.5)mmol·L-1
2 h plasma glucose (2 hPG)(8.5±0.5)VS(9.4±0.6) mmol·L-1
glycosylated hemoglobin A1c(HbA1c)(7.0%±0.4%)VS(7.6%±0.5%). The levels were respectively significantly lower in the observation group (all P<0.05). As to blood lipids
level of total cholesterol(TC) (4.36±0.82)VS(5.21±0.94)mmol·L-1
triglyceride(TG)(1.93±0.68)VS(2.20±0.53)mmol·L-1
low density lipoprotein cholesterol(LDL-C)(3.10±0.54)VS(3.90±0.64)mmol·L-1
respectively statistically lower in the observation group. And level of high density lipoprotein cholesterol(HDL-C)(1.59±0.35)VS (1.29±0.32)mmol·L-1was statistically higher in the observation group than that in the control group after the treatment (all P<0.05). And level of ET-1(70.2±7.4)VS(75.6±8.3) ng·L-1 in the observation group was found statistically lower than that in the control group after the treatment (P<0.05). During the treatment
the incidence of hypoglycemia was 8.1% in the observation group and 4.8% in the control group
with no significant difference. Conclusion:Tangmaikang particles combined with intensive insulin therapy is effective for T2DM
which can significantly increase curative efficacy
improve blood glucose and blood lipids indicators and lower the level of ET-1
in addition
it would not increase the incidence of hypoglycemia
Tangmaikang Particles to Glucose Fluctuation of Patients with Type Two Diabetes Mellitus
Application ofPuerariae Lobatae Radixin Treatment of Type 2 Diabetes Mellitus: A Review
Modified Buwangsan Ameliorates Cognitive Dysfunction in Rat Model of Type 2 Diabetes Mellitus by Regulating Autophagy in Hippocampus via PI3K/Akt/mTOR Pathway
Sequential Administration of Dihuang Baoyuan Granules and Fuling Yunhua Granules for Teating Type 2 Diabetes Mellitus in Mice
Mechanism of Qingrun Prescription-containing Serum Improving Insulin Resistance in HepG2 Cells via Branched-chain α-keto Acid Dehydrogenase Regulation of Branched-chain Amino Acids (BCAAs)/mTOR Pathway
Related Author
HU Man-li
DENG Hong-yan
FU Jie
LIAO Li-ya
LI Liqin
ZENG Zixuan
TANG Ye
ZHOU Xiang
Related Institution
Key Laboratory of Modern Chinese Medicine Formulations of Jiangxi University of Chinese Medicine, Ministry of Education
School of Pharmacy, Jiangxi University of Chinese Medicine
National Key Laboratory of Creation of Modern Chinese Medicine with Classical Formulas
Dongfang Hospital, Beijing University of Chinese Medicine
Key Laboratory of Health Preservation and Rehabilitation, Ministry of Education, Beijing University of Chinese Medicine